Cresco Labs Inc. (CRLBF) Total Current Liabilities (2019 - 2026)

Cresco Labs (CRLBF) has reported Total Current Liabilities for 8 consecutive years, with $137.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 35.9% year-over-year to $137.7 million; the trailing twelve-month figure through Jun 2026 stood at $137.7 million (up 35.9% YoY), and the FY2025 full-year result was $100.2 million, up 6.19% from the prior year.
• Total Current Liabilities improved to $137.7 million in Q2 2026 per CRLBF's latest filing, from $98.2 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $331.2 million in Q1 2022 and bottomed at $94.3 million in Q4 2024.
• Historically, Total Current Liabilities has averaged $183.6 million across 5 years, with a median of $179.4 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities sank 52.89% in 2024, then soared 35.9% in 2026.
• Over 5 years, Total Current Liabilities stood at $255.9 million in 2022, then decreased by 21.74% to $200.2 million in 2023, then tumbled by 52.89% to $94.3 million in 2024, then increased by 6.19% to $100.2 million in 2025, then surged by 37.45% to $137.7 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $137.7 million, $98.2 million, and $100.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.